“Clinical and Economic Rationale for the Early Use of SGLT2 Inhibitors in Patients With Type 2 Diabetes”. Farmeconomia. Health economics and therapeutic pathways 21, no. 1S (December 23, 2020). Accessed October 29, 2025. https://journals.seedstm.com/index.php/FE/article/view/1490.